Eli Lilly’s cease-and-desist letter means “nothing”, says GLP-1 compounder
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
OrderlyMeds, a provider of compounded versions of GLP-1 weight loss drugs, including Eli Lilly’s (NYSE:LLY) tirzepatide, said on Friday that a cease-and-desist letter sent by the pharma giant would mean “nothing” for the company and its business operations.
The